Provided by Tiger Fintech (Singapore) Pte. Ltd.

INDIVIOR PLC

11.56
+0.80007.43%
Post-market: 11.560.00000.00%18:33 EDT
Volume:1.46M
Turnover:16.37M
Market Cap:1.44B
PE:-31.86
High:11.58
Open:10.76
Low:10.52
Close:10.76
Loading ...

Indivior Names Joe Ciaffoni as Chief Executive

MT Newswires Live
·
27 Feb

Indivior Announces Joseph Ciaffoni Appointed Chief Executive Officer

PR Newswire
·
27 Feb

Indivior Announces FDA Approval of Label Changes for SUBLOCADE® (buprenorphine extended-release) Injection

PR Newswire
·
24 Feb

Indivior Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.
·
22 Feb

Indivior’s Earnings Call: Growth Amidst Challenges

TIPRANKS
·
22 Feb

Indivior PLC (INDV) (Q4 2024) Earnings Call Highlights: Strong SUBLOCADE Growth and Strategic ...

GuruFocus.com
·
21 Feb

Indivior's Q4 Adjusted Earnings Fall, Revenue Rises

MT Newswires Live
·
20 Feb

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
20 Feb

Indivior reports Q4 adjusted EPS 32c, consensus 26c

TIPRANKS
·
20 Feb

Stock Track | Indivior Plunges Over 23% in Pre-Market on Disappointing 2025 Guidance

Stock Track
·
20 Feb

Indivior PLC reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
20 Feb

Indivior 2025 Guidance: Expects Net Revenue Of $995M-$1.025B Vs. $1.091B Est.; Sees Adj. Gross Profit Of $185M-$225M

Benzinga
·
20 Feb

Indivior Q4 2024 Adj. EPS $0.32 Beats $0.21 Estimate, Sales $298.000M Beat $259.300M Estimate

Benzinga
·
20 Feb

Indivior Announces FY and Q4 2024 Financial Results

PR Newswire
·
20 Feb

Craig-Hallum Sticks to Its Buy Rating for Indivior (INDV)

TIPRANKS
·
18 Feb

Indivior PLC expected to post earnings of 22 cents a share - Earnings Preview

Reuters
·
18 Feb

Analysts Estimate Indivior PLC (INDV) to Report a Decline in Earnings: What to Look Out for

Zacks
·
13 Feb

Craig-Hallum Sticks to Its Buy Rating for Indivior (INDV)

TIPRANKS
·
12 Feb

Indivior Says US FDA Delays on Sublocade Label Changes Decision

MT Newswires Live
·
12 Feb

Indivior announces FDA delay of final review of Sublocade label changes

TIPRANKS
·
12 Feb